U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839338) titled 'A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive Episodes' on Sept. 18.
Brief Summary: Patients with depression are acutely distressed, often suicidal, and unable to meet the demands of everyday life. If proven effective in a rigorously conducted multicenter randomized controlled trial (RCT), oral ketamine would provide an affordable and scalable, intervention suitable for integration into routine psychiatric services.This study will establish an indigenous, cost-effective therapeutic strategy that could improve accessibility, hasten therapeutic response, and inform treatment guidelines, if ...